WORKING IN PRACTICES WITH CONTRASTING POPULATION NEEDS AND ALTERNATIVE FUNDING MODELS GP runs population relay between practices
People In Health Care Series
Dr Jaspreet Saini, GP
Clinic Director, Healthicare &
Practice Owner and Principal GP, Rosedale Medical Practice
Filmed in Rooty Hill, New South Wales | October 2024
Dr Jaspreet Saini is a GP with a decade of experience, practicing in West Pennant Hills and Rooty Hill, New South Wales. He began his medical journey at Monash University, followed by internships and residency at Blacktown Hospital, in Western Sydney. Instead of confining himself to a single specialty, he pursued general practice to explore various facets of medicine.
His career philosophy centres around addressing frustrations within the healthcare system and advocating for multidisciplinary care. This commitment led him to travel to the United States, where he studied diverse healthcare models, particularly in underserved areas. Recognising the potential for improving primary care in Australia, he and his wife purchased a practice in West Pennant Hills in 2019, which has since received multiple awards for its innovative care approach.
However, Dr Saini felt a strong urge to work in a more underserved community to tackle health equity issues. He has been actively involved in a clinic in Rooty Hill since February 2024, focusing on redesigning healthcare delivery in an area characterised by socio-economic challenges and high rates of chronic conditions like obesity and diabetes.
His typical workweek has evolved to blend clinical practice with leadership and management. Three days a week, he coaches healthcare teams, guiding GPs, nurses, and medical assistants to enhance their clinical skills. Additionally, he engages in research related to health equity and models of care, seeking grants and writing papers.
Collaborative partnerships are pivotal to his approach. In Rooty Hill, his practice works closely with organisations like the Western Sydney Diabetes team, adopting proactive strategies to manage patients’ chronic conditions effectively. Through teamwork, they aim to provide holistic and efficient care, recognising that silos within healthcare hinder optimal outcomes.
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
-
Sharing the same goals in value-based procurement
Value-based procurement (VBP) is a journey, not a sprint. It’s about putting the patient at the centre of quality affordable healthcare through changes in procurement practices for medical technologies. Patient outcomes drive value and sustainability, not just price. The bigger picture indicates that VBP will create system cost saving through benefitting patients, rather than trying to attain the reverse – a win-win outcome.
-
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy (Source: https://www1.racgp.org.au/ajgp/2021/october/medicinal-cannabis)
Australian Health Journal met with 3 speakers at the recent @arcsaustralia ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
